172 related articles for article (PubMed ID: 37442189)
61. Identification of Novel Biomarkers Related to Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis.
Wang H; Huang L; Chen L; Ji J; Zheng Y; Wang Z
Comput Math Methods Med; 2021; 2021():9059116. PubMed ID: 34659450
[TBL] [Abstract][Full Text] [Related]
62. Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin decoction in treating colorectal cancer.
Li YJ; Tang DX; Yan HT; Yang B; Yang Z; Long FX
World J Clin Cases; 2023 Jul; 11(19):4553-4566. PubMed ID: 37469733
[TBL] [Abstract][Full Text] [Related]
63. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
Yu Y; Cheng J; Mei CZ; Dai YZ
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
[TBL] [Abstract][Full Text] [Related]
64. High Expression Levels of CDK1 and CDC20 in Patients With Lung Squamous Cell Carcinoma are Associated With Worse Prognosis.
Deng H; Hang Q; Shen D; Ying H; Zhang Y; Qian X; Chen M
Front Mol Biosci; 2021; 8():653805. PubMed ID: 34307447
[No Abstract] [Full Text] [Related]
65. Study on the Mechanism of Liuwei Dihuang Pills in Treating Parkinson's Disease Based on Network Pharmacology.
Lin D; Zeng Y; Tang D; Cai Y
Biomed Res Int; 2021; 2021():4490081. PubMed ID: 34746302
[TBL] [Abstract][Full Text] [Related]
66. A Hypoxia-Related Signature for Predicting Prognosis, Cellular Processes, Immune Microenvironment and Targeted Compounds in Lung Squamous Cell Carcinoma.
Wu G; Zhu Z; Yang Z; He M; Ren K; Dong Y; Xue Q
Int J Gen Med; 2022; 15():3991-4006. PubMed ID: 35437352
[TBL] [Abstract][Full Text] [Related]
67. In silico analysis revealed the potential circRNA-miRNA-mRNA regulative network of non-small cell lung cancer (NSCLC).
Balasundaram A; C GPD
Comput Biol Med; 2023 Jan; 152():106315. PubMed ID: 36495751
[TBL] [Abstract][Full Text] [Related]
68. Evaluation of the HOXA11 level in patients with lung squamous cancer and insights into potential molecular pathways via bioinformatics analysis.
Zhang R; Zhang TT; Zhai GQ; Guo XY; Qin Y; Gan TQ; Zhang Y; Chen G; Mo WJ; Feng ZB
World J Surg Oncol; 2018 Jun; 16(1):109. PubMed ID: 29914539
[TBL] [Abstract][Full Text] [Related]
69. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma.
Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J
DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870
[TBL] [Abstract][Full Text] [Related]
70. Molecular mechanisms of Tetrastigma hemsleyanum Diels&Gilg against lung squamous cell carcinoma: From computational biology and experimental validation.
Li P; Wang C; Chen G; Han Y; Lu H; Li N; Lv Y; Chu C; Peng X
J Ethnopharmacol; 2024 Sep; 331():118326. PubMed ID: 38750988
[TBL] [Abstract][Full Text] [Related]
71. The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation.
Gao L; Guo YN; Zeng JH; Ma FC; Luo J; Zhu HW; Xia S; Wei KL; Chen G
Int J Oncol; 2019 May; 54(5):1651-1664. PubMed ID: 30896821
[TBL] [Abstract][Full Text] [Related]
72. Clinical Value and Potential Mechanism of miRNA-33a-5p in Lung Squamous Cell Carcinoma.
Wang XM; Chen SW; Chen G; Zhou HF; Gan TQ; Zeng JJ; Li ZY
Anal Cell Pathol (Amst); 2021; 2021():6614331. PubMed ID: 34888137
[TBL] [Abstract][Full Text] [Related]
73. Establishment of a prognostic model toward lung squamous cell carcinoma based on m
Wang Y; Liu Y; Wang R; Cao F; Guan Y; Chen Y; An B; Qin S; Yao S
Physiol Genomics; 2023 Oct; 55(10):427-439. PubMed ID: 37575065
[TBL] [Abstract][Full Text] [Related]
74. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.
Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871
[TBL] [Abstract][Full Text] [Related]
75. Study on the active ingredients and mechanism of action of Jiaotai Pill in the treatment of type 2 diabetes based on network pharmacology: A review.
Chen X; Yang Z; Du L; Guan Y; Li Y; Liu C
Medicine (Baltimore); 2023 Mar; 102(13):e33317. PubMed ID: 37000070
[TBL] [Abstract][Full Text] [Related]
76. Molecular Mechanism of
Zhang W; Shi G; Wang H; Feng M; Gao X; Xie Q; Zhang N; Lv Z
Front Aging Neurosci; 2022; 14():925072. PubMed ID: 35992596
[TBL] [Abstract][Full Text] [Related]
77. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
78. Four hub genes regulate tumor infiltration by immune cells, antitumor immunity in the tumor microenvironment, and survival outcomes in lung squamous cell carcinoma patients.
Zhang T; Yang H; Sun B; Yao F
Aging (Albany NY); 2021 Jan; 13(3):3819-3842. PubMed ID: 33428598
[TBL] [Abstract][Full Text] [Related]
79. The mechanism of Xihuang pills' intervention in the tumour immune microenvironment for the treatment of liver cancer based on the STAT3-PDL1 pathway.
Wang Y; Wang W; Liu K; Liu Y; Shen X; Li Q; Deng F; Hao X; Wang Y
J Ethnopharmacol; 2024 Sep; 331():118278. PubMed ID: 38710457
[TBL] [Abstract][Full Text] [Related]
80. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
